Skip to main content

Research Repository

Advanced Search

Ms ELEANOR MITCHELL's Outputs (63)

Cord pilot trial - immediate versus deferred cord clamping for very preterm birth (before 32 weeks gestation): study protocol for a randomized controlled trial (2014)
Journal Article
Pushpa-Rajah, A., Bradshaw, L., Dorling, J., Gyte, G., Mitchell, E. J., Thornton, J., & Duley, L. (2014). Cord pilot trial - immediate versus deferred cord clamping for very preterm birth (before 32 weeks gestation): study protocol for a randomized controlled trial. Trials, 15(258), https://doi.org/10.1186/1745-6215-15-258

Background: Preterm birth is the most important single determinant of adverse outcome in the United Kingdom; one in every 70 babies (1.4%) is born before 32 weeks (very preterm), yet these births account for over half of infant deaths.
Deferring cor... Read More about Cord pilot trial - immediate versus deferred cord clamping for very preterm birth (before 32 weeks gestation): study protocol for a randomized controlled trial.

UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial (2012)
Journal Article
Craig, F. F., Thomas, K. S., Mitchell, E. J., Williams, H. C., Norrie, J., Mason, J. M., & Ormerod, A. D. (2012). UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial. Trials, 13(1), Article 51. https://doi.org/10.1186/1745-6215-13-51

RCT of treatments for pyoderma gangrenosum: time to get involved (2010)
Journal Article
Mitchell, E. (2010). RCT of treatments for pyoderma gangrenosum: time to get involved. Wounds UK, 6(4), 27-32

Background: Pyoderma gangrenosum (PG) is a rare, painful ulcerating skin condition that is often associated with underlying systemic disease such as inflammatory bowel disease, rheumatoid arthritis and haematological malignancies. There has been litt... Read More about RCT of treatments for pyoderma gangrenosum: time to get involved.